Leaving BNY Website

 

You are leaving the BNY Mellon's Depositary Receipts' Website.
Linked sites are not under the control of The Bank of New York Mellon Corporation or any of its subsidiaries or affiliates (together, the "Company") and the Company is not responsible for the content of any linked site or any link contained in a linked site. If you choose to link to a website not controlled by the Company, you do so entirely at your own risk and the Company makes no warranties, either express or implied, concerning the content of such site, including the accuracy, completeness, reliability or suitability thereof for any particular purpose, nor does the Company warrant that such site or content is free from any claims of copyright, trademark or other infringement of the rights of third parties or that such site or content is devoid of viruses or other contamination. The Company does not guarantee the authenticity of documents on the Internet. Links to other sites do not imply any endorsement of or responsibility for the opinions, ideas, products, information or services offered at such sites, or any representation regarding the content at such sites. The Company reserves the right to terminate any link at any time.

Do you wish to continue to the linked site on these terms?

Stay On Page
Leave Page

© 2025 The Bank of New York Mellon Corporation

Depositary Receipt business and services are conducted through The Bank of New York Mellon.

BNY - DR Legal Disclaimer
  

To learn more about DRs, please contact DRBrokerSolutions@bny.com.

 

The information and data provided herein are provided for general informational purposes only.  BNY does not warrant or guarantee the accuracy, timeliness or completeness of any such information or data.  BNY does not undertake any obligation to update or amend any information or data, and may change, update or amend any information or data at any time without prior notice.

 

BNY provides no advice, recommendation or endorsement with respect to any company or securities.  No information or data is intended to provide legal, tax, accounting, investment, financial, trading or other advice on any matter, and is not to be used as such.  We expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon any information or data, including market value loss on the sale or purchase of securities or other instruments or obligations.

 

Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.

 

BNY collects fees from DR holders pursuant to the terms and conditions of the DRs and any deposit agreement under which they are issued.  From time to time, BNY may make payments to an issuer to reimburse and/or share revenue from the fees collected from DR holders, or waive fees and expenses to an issuer for services provided, generally related to costs and expenses arising out of establishment and maintenance of the DR program.  BNY may pay a rebate to brokers in connection with unsponsored DR issuances; brokers may or may not disclose or pass back some or all of such rebate to the DR investor.  BNY may also use brokers, dealers or other service providers that are affiliates and that may earn or share fees and commissions.

 

BNY may execute DR foreign currency transactions itself or through its affiliates, or the Custodian or the underlying Company may execute foreign currency transactions and pay US dollars to BNY.  In those instances where it executes DR foreign currency transactions itself or through its affiliates, BNY acts as principal counterparty and not as agent, advisor, broker or fiduciary.  In such cases, BNY  has no obligation to obtain the most favorable exchange rate, makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate. BNY earns and retains revenue on its executed foreign currency transactions based on, among other things, the difference between the rate it assigns to the transaction and the rate that it pays and receives for purchases and sales of currencies when buying or selling foreign currency for its own account.  The methodology used by BNY to determine DR conversion rates is available to registered Owners upon request or can be accessed here.  In those instances where BNY's Custodian executes DR foreign currency transactions, the Custodian has no obligation to obtain the most favorable exchange rate or that the method by which the rate will be determined will be the most favorable rate, and BNY makes no representation that the rate is a favorable rate and will not be liable for any direct or indirect losses associated with the rate.  In certain instances, BNY may receive dividends and other distributions from an issuer of securities underlying DRs in U.S. dollars rather than in a foreign currency.  In such cases, BNY will not engage in or be responsible for any foreign currency transactions and it makes no representation that the rate obtained by an issuer is a favorable rate and it will not be liable for any direct or indirect losses associated with the rate.

 

BNY is a global investments company dedicated to helping its clients manage and service their financial assets throughout the investment lifecycle.  BNY is the corporate brand of The Bank of New York Mellon Corporation (NYSE: BK).

 

BNY's name, brand and/or trademarks may not be used, copied or reproduced without the prior express written consent of BNY.

 

DEPOSITARY RECEIPTS ARE NOT INSURED BY THE FDIC OR ANY OTHER GOVERNMENT AGENCY, ARE NOT DEPOSITS OR OTHER OBLIGATIONS OF, AND ARE NOT GUARANTEED BY, BNY AND ARE SUBJECT TO INVESTMENT RISKS INCLUDING POSSIBLE LOSS OF PRINCIPAL AMOUNT INVESTED.

 

Please also see "Terms of Use."

ACCEPT

Please enable cookies in your browser if you wish to proceed.

Regulation S Disclaimer

 

Access To This Company Profile Is Restricted To Non-U.S. Persons Outside The United States Within The Meaning Of Regulation S Under The U.S. Securities Act Of 1933, As Amended (The "Securities Act").1

 

This company profile does not constitute an offer to sell or the solicitation of an offer to buy any securities in any jurisdiction or under any circumstances in which such offer or solicitation is unlawful.

 

Each person accessing this company profile, by so doing, will be deemed to have acknowledged that: (1) It is not a U.S. person (within the meaning of Regulation S under the Securities Act) and is located outside the U.S. (within the meaning of Regulation S under the Securities Act); and (2) Any securities described herein (A) have not been and will not be registered under the Securities Act or with any securities regulatory authority of any state or other jurisdiction and (B) may not be offered, sold, pledged or otherwise transferred except to persons outside the U.S. in accordance with Regulation S under the Securities Act pursuant to the terms of such securities.

 

If you agree with and accept the foregoing and the Terms of use governing this site, please select "Accept" below. Otherwise, press "Decline" to return to the previous page.

 

1 As defined in the Securities Act, the term "U.S Person" means: (1) any natural person resident in the United States; (2) any partnership or corporation organized or incorporated under the laws of the United States; (3) any estate of which any executor or administrator is a U.S. person; (4) any trust of which any trustee is a U.S. person; (5) any agency or branch of a foreign entity located in the United States; (6) any non-discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary for the benefit or account of a U.S. person; (7) any discretionary account or similar account (other than an estate or trust) held by a dealer or other fiduciary organized, incorporated, or (if an individual) resident in the United States; and (8) any partnership or corporation if: (A) organized or incorporated under the laws of any foreign jurisdiction; and (B) formed by a U.S. person principally for the purpose of investing in securities not registered under the Securities Act, unless it is organized or incorporated, and owned, by accredited investors (as defined in Rule 501(a)) who are not natural persons, estates or trusts.

I Accept Decline

© 2024 The Bank of New York Mellon Corporation
Depositary Receipt business and services are conducted through The Bank of New York Mellon.

Back to Daily DR Market Summary

StreetAccount Summary - EU Market Recap: FTSE 100 (0.43%) to 7593.22, DAX (0.25%) to 15217.45, CAC40 (0.03%) to 7071.79, STOXX 600 (0.18%) to 446.91

Sep 27 ,2023

  • Synopsis:

    • European indices ended mostly mixed to lower with Norway and Netherlands exceptions to the negative trend. In sectors, energy the outsized gainer whilst real estate, utilities and insurance the main laggards. No change in broader narrative. Market tone remains cautious amid nervousness over prospect of higher-for-longer rates.

    • In central banks, ECB's Elderson says rates haven't necessarily peaked in interview with MNI from 22-Sept. Austrian central bank chief Holzmann, a known ECB hawk, suggested persistent inflationary pressures may yet lead to further rate hikes. Holzmann pointed to potential spillover from higher oil prices, but also acknowledged trade-off with economic resilience. Added ECB should raise mininum reserves of commercial banks to 5-10%.

    • On the political front, focus on Spain as conservative leader Alberto Nunez Feijoo failed on Wednesday to secure enough votes in the lower house to become prime minister, Reuters reports. Feijoo will have a second attempt on Friday, when a simple majority would be enough for him to be elected prime minister, however is widely expected to lose, paving the way for Socialist leader Sanchez to make a bid for premiership.

    • Amongst today's notable macro releases, German GfK consumer confidence for October fell to (26.5) versus consensus (26.0) and prior revised (25.6) from (25.5). GfK highlighted increase in appetite to save was the main driver. Rose 7.5 points to 8.0, the highest level since Apr-11. Also, France Sep Consumer Confidence deteriorated to 83 vs forecast 84 and prior 85. Elsewhere, Eurozone Aug M3 Money Supply decreased by (1.3%) y/y vs consensus (1.0%) and prior (0.4%). Out of Italy, the asset management association reported latest numbers recording a total net outflows of (€3.38B) in August vs prior outflow (€3.82B).

    • In earnings, out of DACHs, Hornbach Holding (HBH.GR), Helvetia Holding (HELN.SW) and KWS Saat (KWS.GR) posted their latest numbers whilst - in the UK - Allergy Therapeutics (AGY.LN), Saga Plc (SAGA.LN), NCC Group (NCC.LN) and Pendragon (PDG.LN) issued earnings updates, with the latter also confirming that it has received an unsolicited proposal from AutoNation, Inc. (AN) at 32p/sh in cash. In France, Arkema (AKE.FP) is holding its CMD today and disclosed target to achieve sales of around €12B with an elevated EBITDA margin of around 18% by 2028. In Sweden, H&M (HM.B.SS) released Q3 numbers and also the initiation of a new SEK 3B share buyback.

    • On the M&A newsflow, press reports suggest Spain is considering imposing conditions on Saudi Telecom's (7010.AB) acquisition of 9.9% stake in Telefonica (TEF.SM), whilst Flutter Entertainment (FLTR.LN) agreed to acquire an initial 51% stake in MaxBet for a cash consideration of €141M

    • Looking ahead to tomorrow's EU econ-calendar, main releases will include, amongst others, Germany Sep preliminary CPI, Eurozone Sep economic sentiment, Italy Sep business/consumer confidence and Aug PPI, Spain Sep preliminary CPI and Aug retail sales.

  • Digest:

    • Sectors - STOXX Europe 600:

      • Outperformers

        • Oil & Gas +1.55%, Ind Goods & Svcs +0.77%, Technology +0.60%, Basic Resources +0.42%, Banks +0.30%, Media +0.16%, Construct & Mtls +0.12%, Retail +0.07%, Travel & Leisure +0.05%, Autos & Parts (0.13%), Chemicals (0.14%)

      • Underperformers

        • Real Estate(2.00%), Utilities (1.76%), Insurance (1.65%), Telecom (1.27%), Food & Beverage (1.08%), Financial Svcs (0.81%), Persnl & HHold Goods (0.59%), Health Care (0.39%)

    • Macro:

      • Central banks:

        • ECB's Holzmann Floats Tenfold Hike in Minimum Reserves -- Bloomberg

      • EU:

        • Euro zone 2024 fiscal tightening seen limited by slowing economy -- Reuters

      • UK:

        • EU about to cave to UK over hated 'Brexit revenge' tariffs in EV trade showdown today -- Express

        • Poll shows Tory London mayor contender Susan Hall just three points behind Sadiq Khan after ULEZ fury -- DailyMail

      • Germany:

        • Unemployment is falling, inflation will fall below two percent in 2025 -- Handelsblatt, citing five leading economic research institutes

      • France:

        • Notice relating to the draft laws of finance and social security financing for the year 2024 -- High Council of Public Finance (HCFP)

        • France unveils modest spending cuts for next year -- FT

      • Italy:

        • Exclusive: Italy in talks with Bavaria on gas and hydrogen exports, eyes eastern Europe -- Reuters

      • Spain:

        • Spain's conservative leader Feijoo fails in first bid to become prime minister -- Reuters

    • Company news:

      • Notable Gainers

        • +30.8% SIGHT.FP (GenSight Biologics €0.70, +0.16) -- updates on LUMEVOQ EMA scientific advice

        • +30.6% ONWD.BB (Onward Medical €4.05, +1.03) -- first-in-Human implant of ARC-IM stimulator with brain-computer interface (BCI)

        • +16.7% ENSU.NO (Ensurge Micropower NOK0.13, +0.02) -- to host a Company update presentation

        • +11.4% PDG.LN (Pendragon £0.33, +0.03) -- H1 earnings

        • +11.2% VSCA.GR (4SC €9.30, +1.05) -- Orphan Drug Designation (ODD) for resminostat (Kinselby) in CTCL from US FDA

        • +10.4% PANR.LN (Pantheon Resources £0.29, +0.03) -- Alkaid-2 re-entry operations commence

        • +9.9% SHLF.NO (Shelf Drilling NOK35.90, +3.45) -- Completes 19.4M-share private placement at NOK33/sh

        • +8.8% ITH.LN (Ithaca Energy £1.77, +0.14) -- Phase 1 of Rosebank development progress

        • +8.0% LBIRD.FP (Lumibird €13.46, +1.06) -- Q2 earnings

        • +7.6% ODL.NO (Odfjell Drilling NOK35.95, +2.65) -- Phase 1 of Rosebank development progress

        • +5.5% KWS.GR (KWS Saat €55.30, +2.90) -- FY earnings

        • +5.4% ZIN.LN (Zinc Media Group £0.97, +0.05) -- H1 earnings

        • +4.2% BIOS.BB (BioSenic €0.12, +0.01) -- completes post-hoc analysis of its phase 2 clinical trial of ATO

        • +3.8% AGY.LN (Allergy Therapeutics £0.03, -0.00) -- FY earnings; circular to shareholders in relation to the open offer

        • +3.7% ADYEN.NA (Adyen €699.00, +24.10) -- Barclays upgrade

        • +3.4% HM.B.SS (H&M Hennes & Mauritz SEK161.70, +5.26) -- Q3 earnings

        • +2.0% ICP.LN (Intermediate Capital Group £14.01, +0.27) -- BNP Paribas Exane upgrade

        • +1.9% COPN.SW (Cosmo Pharmaceuticals CHF41.70, +0.75) -- Distribution and License agreements for Winlevi in Europe and South Africa

        • +1.8% MITRA.BB (Mithra Pharmaceuticals €1.88, +0.03) -- presentation of positive data on Estetrol (E4) native Estrogen at NAMS 2023

      • Notable Decliners

        • -18.8% NN.NA (NN Group €31.47, -6.81) -- Court of Appeal judgement in respect to unit-linked insurances labelled Flexibel Verzekerd Beleggen; Oddo downgrade

        • -16.0% VLTSA.FP (Voltalia €11.38, -2.08) -- H1 earnings

        • -13.5% PHC.LN (Plant Health Care £0.08, -0.01) -- H1 earnings

        • -6.2% TEG.GR (TAG Immobilien €9.62, -0.61) -- HSBC downgrade

        • -5.8% ALHRG.FP (HERIGE €25.10, -1.60) -- Q2 earnings

        • -5.0% CNA.LN (Centrica £1.58, -0.08) -- Morgan Stanley downgrade; initiated sell at Liberum Capital

        • -4.9% GPE.LN (Great Portland Estates £4.14, -0.21) -- Jefferies downgrade

        • -4.6% MAAT.FP (Maat Pharma €5.90, -0.26) -- H1 earnings

        • -1.2% AVG.LN (Avingtrans £3.80, -0.05) -- FY earnings

    • EU companies reporting tomorrow:

      • Earnings:

        • Benelux: Fluxys Belgium (FLUX.BB)

        • France: Virbac (VIRP.FP), Carbios (ALCRB.FP), Marie Brizard Wine & Spirits (MBWS.FP), Evolis (ALTVO.FP), Inventiva (IVA.FP), Precia (PREC.FP), ATEME (ATEME.FP), Xilam Animation (XIL.FP), Novacyt (ALNOV.FP), Valerio Therapeutics (ALVIO.FP), METabolic EXplorer (METEX.FP), ABIONYX Pharma (ABNX.FP), Mauna Kea Technologies (ALMKT.FP)

        • DACHs: PharmaSGP (PSG.GR), cyan (CYR.GR)

        • Southern Europe: Philogen (PHIL.IM), Expert.ai (EXAI.IM), Bastogi (B.IM)

        • UK: Ceres Power (CWR.LN), Avacta (AVACT.LN), Microlise (SAAS.LN), HSS Hire Group (HSS.LN), Shield Therapeutics (STX.LN), Hansard Global (HSD.LN), Trinity Exploration & Production (TRIN.LN), XLMedia (XLM.LN), RBG Holdings (RBGP.LN)

  • Data:

    • Economics:

      • Germany Oct GfK Consumer Confidence (26.5) vs consensus (26.0) and prior revised (25.6) from (25.5)

      • France Sep Consumer Confidence 83 vs consensus 84 and prior 85

      • Switzerland Sep ZEW Expectations (27.6) vs consensus (36.0) and prior (38.6)

      • Norway Aug Unemployment Rate 3.6% vs consensus 3.5% and prior revised 3.6% from 3.5%

      • Sweden Aug Trade Balance (SEK8.40B) vs consensus (SEK5.5B) and prior revised to SEK 6.10B from SEK4.6B

      • Eurozone Aug M3 Money Supply (1.3%) y/y vs consensus (1.0%) and prior (0.4%)

    • Markets:

      • WTI Crude (23-Nov): +$3.33 or +3.68% to $93.72

      • €-$ (0.0050) or (0.47%) to 1.0523

      • £-$ (0.0007) or (0.06%) to 1.2150

      • €-£ (0.0034) to 0.8663

      • S&P 500 (0.01%)

      • Performance year-to-date:

        • FTSE 100: +1.90%

        • DAX: +9.29%

        • CAC: +9.24%

        • MIB: +18.16%

        • Stoxx 600: +5.18%

This information and data is provided for general informational purposes only. The Bank of New York Mellon and our information suppliers do not warrant or guarantee the accuracy, timeliness or completeness of this information or data. We provide no advice nor recommendation or endorsement with respect to any company or securities. We do not undertake any obligation to update or amend this information or data. Nothing herein shall be deemed to constitute an offer to sell or a solicitation of an offer to buy securities.
Please refer to "Terms Of Use".

DEPOSITARY RECEIPTS:
NOT FDIC, STATE OR FEDERAL AGENCY INSURED
MAY LOSE VALUE
NO BANK, STATE OR FEDERAL AGENCY GUARANTEE